|
| 36493617 | New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action. | Eur J Med Chem | 2023 |
| 35214160 | Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines. | Pharmaceutics | 2022 |
| 35456549 | Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors. | Pharmaceutics | 2022 |
| 34290243 | 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine. | Nat Commun | 2021 |
| 34575436 | Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors. | Pharmaceutics | 2021 |
| 34834257 | New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial Activity. | Pharmaceutics | 2021 |
| 32977218 | Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism. | Eur J Med Chem | 2020 |
| 31727470 | Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs). | Eur J Med Chem | 2020 |
| 30633509 | Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors. | J Med Chem | 2019 |
| 31408964 | Biomimetic Magnetic Nanocarriers Drive Choline Kinase Alpha Inhibitor inside Cancer Cells for Combined Chemo-Hyperthermia Therapy. | Pharmaceutics | 2019 |
| 30911014 | Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells. | Sci Rep | 2019 |
| 29220790 | 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. | Eur J Med Chem | 2018 |
| 30043647 | Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors. | Future Med Chem | 2018 |
| 29880399 | 1,2-Diphenoxiethane salts as potent antiplasmodial agents. | Bioorg Med Chem Lett | 2018 |
| 30093861 | Enhancement of Tumor Cell Death by Combining <i>gef</i> Gene Mediated Therapy and New 1,4-Benzoxazepin-2,6-Dichloropurine Derivatives in Breast Cancer Cells. | Front Pharmacol | 2018 |
| 30006194 | EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells. | Biochem Pharmacol | 2018 |
| 30360374 | Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer. | Cancers (Basel) | 2018 |
| 29620429 | Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cells. | J Enzyme Inhib Med Chem | 2018 |
| 28419928 | Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents. | Eur J Med Chem | 2017 |
| 28406191 | Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents. | Sci Rep | 2017 |
| 27029499 | Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1). | Sci Rep | 2016 |
| 26629859 | Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation. | Eur J Med Chem | 2016 |
| 27216165 | Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole. | Sci Rep | 2016 |
| 27402422 | <sup>1</sup> H and <sup>13</sup> C NMR spectral assignments of 1,1'-(((ethane-1,2-diylbis(oxy))bis(4,1-phenylene))bis(methylene))-bispyridinium and -bisquinolinium bromide derivatives. | Magn Reson Chem | 2016 |
| 25785605 | Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin. | J Med Chem | 2015 |
| 27490389 | Pharmacophore-Based Virtual Screening to Discover New Active Compounds for Human Choline Kinase α1. | Mol Inform | 2015 |
| 26141910 | Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study. | Eur J Med Chem | 2015 |
| 25875870 | New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1. | Future Med Chem | 2015 |
| 24170481 | 1H, 13C NMR studies of new 3-aminophenol isomers linked to pyridinium salts. | Magn Reson Chem | 2014 |
| 25515750 | Choline kinase active site provides features for designing versatile inhibitors. | Curr Top Med Chem | 2014 |
| 25181013 | Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene. | J Med Chem | 2014 |
| 24332652 | Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the Aâ¿ adenosine receptor. | Bioorg Med Chem | 2014 |
| 24398384 | Design, synthesis and biological evaluation of 3,5-disubstituted 2-amino thiophene derivatives as a novel class of antitumor agents. | Bioorg Med Chem | 2014 |
| 23911855 | Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor. | Eur J Med Chem | 2013 |
| 24080101 | New non-symmetrical choline kinase inhibitors. | Bioorg Med Chem | 2013 |
| 24164557 | Concise synthesis and biological evaluation of 2-Aroyl-5-amino benzo[b]thiophene derivatives as a novel class of potent antimitotic agents. | J Med Chem | 2013 |
| 22182575 | Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the Aâ¿ adenosine receptor. | Bioorg Med Chem | 2012 |
| 23152402 | In silico pharmacology for a multidisciplinary drug discovery process. | Drug Metabol Drug Interact | 2012 |
| 22693150 | NMR spectroscopic characterization of new 2,3-dihydro-1,3,4-thiadiazole derivatives. | Magn Reson Chem | 2012 |
| 22889387 | Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor. | J Med Chem | 2012 |
| 22512552 | Melatonin synthetic analogs as nitric oxide synthase inhibitors. | Mini Rev Med Chem | 2012 |
| 22336385 | 1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence. | Eur J Med Chem | 2012 |
| 21126804 | New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine. | Eur J Med Chem | 2011 |
| 22027100 | One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazole: a unique, highly active antimicrotubule agent. | Eur J Med Chem | 2011 |
| 21805646 | Synthesis and antitumor molecular mechanism of agents based on amino 2-(3',4',5'-trimethoxybenzoyl)benzo[b]furan: inhibition of tubulin and induction of apoptosis. | ChemMedChem | 2011 |
| 20378350 | Symmetrical alpha-bromoacryloylamido diaryldienone derivatives as a novel series of antiproliferative agents. Design, synthesis and biological evaluation. | Bioorg Med Chem Lett | 2010 |
| 20933308 | Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-aryl/arylaminobenzo[b]thiophene derivatives as a novel class of antiproliferative agents. | Eur J Med Chem | 2010 |
| 20676361 | Synthesis and Evaluation of Haloacetyl, α-Bromoacryloyl and Nitrooxyacetyl Benzo[b]furan and Benzo[b]thiophene Derivatives as Potent Antiproliferative Agents Against Leukemia L1210 and K562 Cells. | Lett Drug Des Discov | 2010 |
| 20420439 | Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues. | J Med Chem | 2010 |
| 19250822 | Hybrid alpha-bromoacryloylamido chalcones. Design, synthesis and biological evaluation. | Bioorg Med Chem Lett | 2009 |